IMRN
Immuron Sp ADR (IMRN)
NASDAQ
$1.35+$0.03 (+2.27%)
Price as of Jun 03, 2026 6:06 PM EDT
  • $11.8M
    Market Cap
  • -25.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
7.3M
+48.63%
4.9M
+171.67%
1.8M
+135.85%
765,193
+424.91%
Cost of Revenue
2.5M
+61.03%
1.6M
+216.02%
495,558
+105.04%
241,691
+373.25%
Gross Profit
4.8M
+42.80%
3.3M
+154.88%
1.3M
+150.07%
523,502
+452.77%
Sales and Marketing Expense
3.5M
+70.10%
2.0M
+118.85%
927,423
+122.65%
416,537
+44.79%
Research and Development Expense
-3.6M
-33.08%
-5.4M
+107.38%
-2.6M
+294.11%
-657,715
-51.89%
Depreciation and Amortization Expense
49,688
+8.06%
45,981
-5.51%
48,662
+82.85%
26,613
N/A
Total Operating Expenses
4.5M
-1.58%
4.6M
+7.93%
4.2M
+19.76%
3.5M
-11.42%
Operating Profit
-5.3M
-7.87%
-5.8M
+62.55%
-3.6M
+24.36%
-2.9M
-65.75%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
1.4M
-58.59%
3.4M
+31.51%
2.6M
+170.59%
957,725
+55.20%
Income before Taxes
-5.2M
-24.81%
-6.9M
+83.20%
-3.8M
+32.66%
-2.9M
-65.96%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-5.2M
-24.81%
-6.9M
+83.20%
-3.8M
+32.66%
-2.9M
-65.96%
Net Income from Continuing Operations Applicable to Common
-5.2M
-24.81%
-6.9M
+83.20%
-3.8M
+32.66%
-2.9M
-65.96%
Basic EPS and Net Income
-2.26
-25.66%
-3.04
+83.13%
-1.66
+32.80%
-1.25
N/A
Diluted EPS and Net Income
-2.26
-25.66%
-3.04
+83.13%
-1.66
+32.80%
-1.25
N/A
Basic Weighted Average Shares
230.9M
+1.35%
227.9M
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
230.9M
+1.35%
227.9M
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
2.8M
-75.72%
11.7M
-32.07%
17.2M
-22.39%
22.1M
-11.73%
Short-Term Investments
N/A
N/A
N/A
N/A
404,117
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.8M
-75.72%
11.7M
-33.63%
17.6M
-20.56%
22.1M
-11.73%
Total Current Assets
10.0M
-31.99%
14.7M
-27.85%
20.4M
-13.78%
23.7M
-8.08%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
113,950
-26.17%
154,347
-22.88%
200,133
-11.73%
226,736
+571.99%
Total Long-Term Assets
114,616
-86.08%
823,632
-47.83%
1.6M
+33.39%
1.2M
-8.97%
Total Assets
10.1M
-34.86%
15.5M
-29.28%
22.0M
-11.54%
24.9M
-8.12%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.0M
-27.15%
2.7M
+21.62%
2.2M
+47.65%
1.5M
+33.97%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
94,577
-33.18%
141,546
-7.00%
152,207
-13.25%
175,447
+384.71%
Total Liabilities
2.1M
-27.45%
2.8M
+19.79%
2.4M
+41.28%
1.7M
+44.94%
Retained Earnings
-82.4M
+4.40%
-79.0M
+9.59%
-72.1M
+5.31%
-68.4M
+3.78%
Total Stockholders Equity
8.1M
-36.51%
12.7M
-35.21%
19.6M
-15.36%
23.2M
-10.49%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-6.1M
+4.37%
-5.9M
+126.58%
-2.6M
-17.56%
-3.1M
-22.82%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-2.9M
-985.46%
327,561
+112.50%
-2.6M
-22,433.47%
11,737
+355.98%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
199,747
+23,994.93%
829
+101.86%
-44,667
+5.23%
-42,448
-100.16%
Financials Ratio
Gross Margin
65.39%
-3.92%
68.06%
-6.18%
72.54%
+6.03%
68.41%
+5.31%
Operating Margin
-73.34%
-38.01%
-118.32%
-40.17%
-197.75%
-47.27%
-375.05%
-93.48%
Return on Assets
-40.62%
+9.91%
-36.96%
+128.62%
-16.17%
+47.01%
-11.00%
-78.19%
Return on Equity
-50.21%
+16.98%
-42.92%
+142.53%
-17.70%
+52.12%
-11.63%
-78.12%
Revenue Growth
48.63%
-71.67%
171.67%
+26.37%
135.85%
-68.03%
424.91%
+551.02%
Current Ratio
5.09
-6.65%
5.46
-40.67%
9.20
-41.61%
15.75
-31.39%
Cash Ratio
1.44
-66.67%
4.32
-44.14%
7.73
-47.44%
14.71
-34.11%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow